Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region
(352) 273-9400

Giuseppe Morelli, MD

Gastroenterologist, Transplant Hepatologist

Additional languages:
Italian
Photo of Giuseppe Morelli
(352) 273-9400 MyUFHealth

Research at a glance

Top areas of exploration

  • Liver Transplantation , 15 publications
  • Antiviral Agents , 13 publications
  • Liver Cirrhosis , 12 publications
  • Drug Therapy, Combination , 10 publications

Research activity

64 publications

2,071 citations

Why is this important?

Active clinical trials

ALTA TIPS

ALTA is a multicenter consortium focused on the management of portal hypertension. ALTA TIPS is a longitudinal observational study of patients who are undergoing transjugular intrahepatic portosystemic shunt (TIPS) placement. ALTA will create a…

Investigator
Giuseppe Morelli
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

64 publications

2019

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney Disease.

Kidney international reports

PubMed • Publisher's site

2019

Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy.

Gastroenterology

PubMed • Publisher's site

2019

Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

PubMed • Publisher's site

2019

Multidisciplinary Care for Cystic Fibrosis Liver Disease: Where Does the Adult Hepatologist Fit In?

Clinical liver disease

PubMed • Publisher's site

2018

Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection.

Scientific reports

PubMed • Publisher's site